Modeling neuropsychiatric disorders using human induced pluripotent stem cells
ABSTRACT Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-05-01
|
Series: | Protein & Cell |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13238-019-0638-8 |
id |
doaj-283ddeaf6eda4d5f98b898dc6845e6ee |
---|---|
record_format |
Article |
spelling |
doaj-283ddeaf6eda4d5f98b898dc6845e6ee2020-11-25T03:07:54ZengSpringerOpenProtein & Cell1674-800X1674-80182019-05-01111455910.1007/s13238-019-0638-8Modeling neuropsychiatric disorders using human induced pluripotent stem cellsMeiyan Wang0Lei Zhang1Fred H. Gage2Laboratory of Genetics, The Salk Institute for Biological StudiesLaboratory of Genetics, The Salk Institute for Biological StudiesLaboratory of Genetics, The Salk Institute for Biological StudiesABSTRACT Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding disease etiology and developing effective treatments. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an opportunity to recapitulate disease development in relevant cell types, and they provide novel approaches for understanding disease mechanisms and for development of effective treatments. Here we review recent progress and challenges in differentiation paradigms for generating disease-relevant cells and recent studies of neuropsychiatric disorders using human pluripotent stem cell (hPSC) models where cellular phenotypes linked to disease have been reported. The use of iPSC-based disease models holds great promise for understanding disease mechanisms and supporting discovery of effective treatments.http://link.springer.com/article/10.1007/s13238-019-0638-8neuropsychiatric disordersiPSCsbrain organoidschizophreniaautism spectrum disorderbipolar disorder |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Meiyan Wang Lei Zhang Fred H. Gage |
spellingShingle |
Meiyan Wang Lei Zhang Fred H. Gage Modeling neuropsychiatric disorders using human induced pluripotent stem cells Protein & Cell neuropsychiatric disorders iPSCs brain organoid schizophrenia autism spectrum disorder bipolar disorder |
author_facet |
Meiyan Wang Lei Zhang Fred H. Gage |
author_sort |
Meiyan Wang |
title |
Modeling neuropsychiatric disorders using human induced pluripotent stem cells |
title_short |
Modeling neuropsychiatric disorders using human induced pluripotent stem cells |
title_full |
Modeling neuropsychiatric disorders using human induced pluripotent stem cells |
title_fullStr |
Modeling neuropsychiatric disorders using human induced pluripotent stem cells |
title_full_unstemmed |
Modeling neuropsychiatric disorders using human induced pluripotent stem cells |
title_sort |
modeling neuropsychiatric disorders using human induced pluripotent stem cells |
publisher |
SpringerOpen |
series |
Protein & Cell |
issn |
1674-800X 1674-8018 |
publishDate |
2019-05-01 |
description |
ABSTRACT Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding disease etiology and developing effective treatments. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an opportunity to recapitulate disease development in relevant cell types, and they provide novel approaches for understanding disease mechanisms and for development of effective treatments. Here we review recent progress and challenges in differentiation paradigms for generating disease-relevant cells and recent studies of neuropsychiatric disorders using human pluripotent stem cell (hPSC) models where cellular phenotypes linked to disease have been reported. The use of iPSC-based disease models holds great promise for understanding disease mechanisms and supporting discovery of effective treatments. |
topic |
neuropsychiatric disorders iPSCs brain organoid schizophrenia autism spectrum disorder bipolar disorder |
url |
http://link.springer.com/article/10.1007/s13238-019-0638-8 |
work_keys_str_mv |
AT meiyanwang modelingneuropsychiatricdisordersusinghumaninducedpluripotentstemcells AT leizhang modelingneuropsychiatricdisordersusinghumaninducedpluripotentstemcells AT fredhgage modelingneuropsychiatricdisordersusinghumaninducedpluripotentstemcells |
_version_ |
1724668553603317760 |